可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Rodrigues LR, Teixeira JA, Schmitt FL, et al. The role of osteopontin in tumor progression and metastasis in breast cancer[J]. Cancer Epidemiol Biomarkers Prev, 2007, 16(6):1087-1097.
[2]方欣,管思明. 骨桥蛋白与高血压血管重构[J]. 心脏杂志, 2009, 19(2):232-233.
[3] Scatena M, Liaw L, Giachelli CM. American heart association, Osteopontin a multifunctional molecule regulating chronic inflammation and vascular disease[J]. Arterioscler Thromb Vasc Biol, 2007, 27(11):2302-2309.
[4]Okamoto H. Osteopontin and cardiovascular system[J]. Mol Cell Biochem, 2007, 300(1-2):1-7.
[5]Coskun S, Atalar E, Ozturk E, et al. Plasma osteopontin levels are elevated in non-ST-segment elevation acute coronary syndromes[J]. J Natl Med Assoc, 2006, 98(11):1746-1750.
[6]Minoretti P, Falcone C, Calcagnino M, et al. Prognostic significance of plasma osteopontin levels in patients with chronic stable angina[J]. Eur Heart J, 2006, 27(7):802-807.
[7]Georgiadou P, Iliodromitis EK, Kolokathis F, et al. Plasma levels of osteopontin before and 24h after percutaneous coronary intervention[J]. Expert Opin Ther Targets, 2008, 12(12):1477-1480.
[8]Kato R, Momiyama Y, Ohmori R, et al. Prognostic significance of plasma osteopontin levels in patients undergoing percutaneous coronary intervention[J]. Circ J, 2009, 73(1):152-157.
[9]Kusuyama T, Yoshiyama M, Omura T, et al. Angiotensin blockade inhibits osteopontin expression in non-infarcted myocardium after myocardial infarction[J]. J Pharmacol Sci, 2005, 98(3):283-289.